Systemic sclerosis

0Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Systemic sclerosis is a chronic multisystemic progressive disease that affects the skin and internal organs. Generally, Raynaud’s phenomenon and vascular changes are the first clinical manifestations followed by sclerotic and fibrotic changes. It is a rare disease: the incidence is 8-12 patients per million population and about 75 % of patients are woman. It has the highest case-specific mortality of any of the autoimmune rheumatic diseases: the 5-year survival is about 50-70 % when pulmonary hypertension is present. It is determined by the involvement of the heart and lung (pulmonary fibrosis, pneumonia) and in some populations of higher frequency of the kidney (uraemia, malignant hypertension).

Cite

CITATION STYLE

APA

Zanardelli, M., Zarrab, Z., & Pietrzak, A. (2015). Systemic sclerosis. In European Handbook of Dermatological Treatments, Third Edition (pp. 949–955). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-45139-7_95

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free